Filler Program Director

Filler Program Director – Ipsen Pharma (SAS)

The Hyaluronic Acid (HA) Filler Program Lead is responsible for the evaluation, development, and lifecycle execution of HA filler assets, supporting the build‑out of a competitive global aesthetics portfolio. The portfolio will be primarily built through external innovation, with this role partnering closely with Business Development & Licensing to assess and progress external opportunities. The role does not define portfolio strategy but ensures that selected assets are rigorously evaluated and effectively translated into approvable and commercially viable products. This position sits at the intersection of Business Development, R&D, Regulatory, Medical, and Commercial, ensuring seamless execution from asset assessment through development, industrialization, regulatory approval, and lifecycle management. The HA Filler Program Lead acts as a central integrator and technical expert, responsible for shaping development approaches and driving disciplined execution across internal functions and external partners.

Main Responsibilities

• External Asset Evaluation & Integration – Lead the technical and development assessment of externally sourced HA filler assets in close collaboration with Business Development & Licensing. Evaluate product design and performance characteristics (e.g., rheology, usability), clinical evidence and data packages, regulatory feasibility across key markets, manufacturing robustness and scalability. Identify development gaps, risks, and requirements to ensure assets are fit for progression. Provide clear, cross‑functional recommendations to support asset selection decisions.
• Development Strategy Translation & Program Planning – Translate asset‑level decisions into practical and fit‑for‑purpose development plans. Define evidence requirements (clinical and non‑clinical), regulatory pathways and submission approach, industrialization and technical readiness requirements. Build and maintain integrated program plans covering timelines, milestones, risks, and budget.
• End‑to‑End Development Execution – Lead the execution of HA filler development programs from asset selection through to registration and commercial readiness. Drive cross‑functional delivery across regulatory, clinical development/medical affairs, quality and manufacturing, and supply operations.
• Regulatory & Approval Delivery – Define and drive global regulatory strategy execution for HA fillers. Ensure readiness for CE marking (EU MDR), FDA and other key market registrations. Oversee preparation of technical files, clinical documentation, and submission dossiers. Manage interactions with regulatory stakeholders (internally and externally). Ensure compliance throughout development and submission.
• Manufacturing & Industrialization Readiness – Ensure that externally sourced products are technically and operationally ready for scale‑up and commercial supply. Collaborate with external manufacturing partners and internal quality and supply teams.
• External Partner Management – Act as the primary program lead for external partners (developers, manufacturers, licensors). Ensure alignment on development scope and deliverables. Deliver against agreed timelines, cost, and quality. Drive performance through clear governance and escalation mechanisms. Maintain strong, constructive, and performance‑focused partnerships.
• Cross‑functional Integration & Alignment – Act as the central integrator across internal functions, ensuring alignment between technical/development requirements, regulatory constraints, commercial and medical needs.
• Lifecycle Management Execution – Support and drive post‑approval lifecycle activities, including geographic expansion, indication extensions (where relevant), product updates and improvements. Ensure ongoing compliance and competitiveness of the portfolio.
• Governance & Reporting – Prepare and present program updates, risks, and recommendations to governance bodies. Ensure decision readiness through high‑quality analysis, clear articulation of trade‑offs and risks, and maintain transparency and alignment with senior stakeholders.

Knowledge & Experience

• Advanced degree in a relevant scientific or technical discipline (e.g., Pharmacy, Biomedical Engineering, Life Sciences, Material Science) – preferred.
• 10–15+ years of experience with HA fillers, injectables, or comparable device‑based technologies.
• Proven experience in development and program leadership within a regulated environment (EU MDR, FDA or equivalent).
• Strong track record in leading development of medical devices or injectables from evaluation through to registration and market readiness.
• Experience working with external partners (manufacturers, licensors, developers, CDMOs) and cross‑functional global teams (Regulatory, Quality, Clinical, Manufacturing, Commercial).

Nous nous engageons à créer un lieu de travail où chacun se sent écouté, valorisé et soutenu, où nous incarnons « The Real Us ». La valeur que nous accordons aux différentes perspectives et expériences motive notre engagement en faveur de l’inclusion et de l’égalité des chances. Lorsque nous intégrons des modes de pensée diversifiés, nous prenons des décisions plus réfléchies et découvrons des solutions plus innovantes. Ensemble, nous nous efforçons de mieux comprendre les communautés que nous servons. Cela signifie que nous voulons également vous aider à donner le meilleur de vous-même lorsque vous postulez à un poste chez nous. Si vous avez besoin d’aménagements ou d’aide pendant le processus de candidature, veuillez en informer l’équipe de recrutement. Ces informations seront traitées avec soin et n’auront aucune incidence sur le résultat de votre candidature. Soyons nous‑même